Tonix to stop testing drug for fibromyalgia, shares plunge

(Reuters) - Tonix Pharmaceuticals Holding Corp said it would stop developing its drug for fibromyalgia and focus on a late-stage trial testing the treatment in patients with post-traumatic stress disorder (PTSD).